Cargando…

Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment

Detalles Bibliográficos
Autores principales:	Yoshida, Reiko, Nakamura, Seigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816858/ https://www.ncbi.nlm.nih.gov/pubmed/36618808 http://dx.doi.org/10.21037/atm-2022-65

Ejemplares similares

Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board
por: Xavier, Camila B, et al.
Publicado: (2023)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
por: Sella, Tal, et al.
Publicado: (2022)

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
por: Gagnon, Marie-France, et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity
por: Feldkamp, Jasper David, et al.
Publicado: (2022)

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
por: Huang, Yi-Chun, et al.
Publicado: (2021)

Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury
por: Vlasschaert, Caitlyn, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
por: Miller, Peter G., et al.
Publicado: (2022)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
por: Komic, Luka, et al.
Publicado: (2023)

Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
por: Swaminathan, Aparna C., et al.
Publicado: (2023)

Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology Disorders
por: Ferrer, Alejandro, et al.
Publicado: (2022)

Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
por: Burns, Sarah S., et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2021)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
por: Uddin, M d Mesbah, et al.
Publicado: (2022)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
por: Kuhnert, Stefan, et al.
Publicado: (2022)

Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
por: Schenz, Judith, et al.
Publicado: (2022)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
por: Schuermans, Art, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
por: Burns, Sarah S., et al.
Publicado: (2020)

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative
por: Haring, Bernhard, et al.
Publicado: (2021)

Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation
por: Goldman, Elisabeth A., et al.
Publicado: (2023)

Association of Clonal Hematopoiesis of Indeterminate Potential with Incident Heart Failure with Preserved Ejection Fraction
por: Reiner, Alex P., et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020)

Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017)

Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
por: Park, Derek S., et al.
Publicado: (2019)

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
por: Denicolò, Sara, et al.
Publicado: (2022)

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
por: Nakao, Tetsushi, et al.
Publicado: (2022)

Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
por: Li, Yong, et al.
Publicado: (2022)

P1642: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL ARE ASSOCIATED WITH INCREASED NETOSIS IN PATIENTS WITH CARDIOVASCULAR EVENTS
por: Marti, Severine, et al.
Publicado: (2023)

Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
por: von Scheidt, Moritz, et al.
Publicado: (2023)

Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to atherlosclerotic cardio/cerebro-vascular diseases?
por: Li, Fei, et al.
Publicado: (2018)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential
por: Vela, Cory M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7nc7pcid1bf7e07nkftmarj4nh